MW1685A1 - N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents - Google Patents

N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents

Info

Publication number
MW1685A1
MW1685A1 MW16/85A MW1685A MW1685A1 MW 1685 A1 MW1685 A1 MW 1685A1 MW 16/85 A MW16/85 A MW 16/85A MW 1685 A MW1685 A MW 1685A MW 1685 A1 MW1685 A1 MW 1685A1
Authority
MW
MALAWI
Prior art keywords
oxindole
carboxamides
disubstituted
analgesic
inflammatory agents
Prior art date
Application number
MW16/85A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MW1685A1 publication Critical patent/MW1685A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MW16/85A 1984-05-04 1985-05-03 N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents MW1685A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (1)

Publication Number Publication Date
MW1685A1 true MW1685A1 (en) 1986-09-10

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
MW16/85A MW1685A1 (en) 1984-05-04 1985-05-03 N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL145416B1 (en)
PT (1) PT80375B (en)
RO (2) RO94455B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
AR241159A1 (en) 1991-12-30
PL257892A1 (en) 1986-10-07
AR241159A2 (en) 1991-12-30
HUT37754A (en) 1986-02-28
PL147508B1 (en) 1989-06-30
FI851756L (en) 1985-11-05
IN161509B (en) 1987-12-19
CS252828B2 (en) 1987-10-15
DD232916A5 (en) 1986-02-12
PL145416B1 (en) 1988-09-30
KR870000497B1 (en) 1987-03-12
JPH0335315B2 (en) 1991-05-27
ES542813A0 (en) 1986-07-16
IE851103L (en) 1985-11-04
MX5839A (en) 1993-11-01
RO91141A (en) 1987-06-30
YU44998B (en) 1991-06-30
RU2017729C1 (en) 1994-08-15
HU196057B (en) 1988-09-28
CS320285A2 (en) 1987-03-12
PT80375A (en) 1985-05-01
ES8707182A1 (en) 1987-07-16
FI851756A0 (en) 1985-05-03
BG60207B2 (en) 1993-12-30
RO91141B (en) 1987-07-03
NO163132B (en) 1990-01-02
NO163132C (en) 1990-04-11
RO94455A (en) 1988-06-30
ZA853324B (en) 1986-12-30
YU73085A (en) 1988-04-30
FI80016B (en) 1989-12-29
MA20424A1 (en) 1985-12-31
EG17193A (en) 1990-08-30
SU1468413A3 (en) 1989-03-23
KR850008154A (en) 1985-12-13
PL253203A1 (en) 1986-06-17
ES551275A0 (en) 1987-07-16
ES8609248A1 (en) 1986-07-16
OA08098A (en) 1987-03-31
FI80016C (en) 1990-04-10
ZW7885A1 (en) 1985-07-24
RO94455B (en) 1988-07-01
JPS60243068A (en) 1985-12-03
PT80375B (en) 1987-09-30
BG60208B2 (en) 1993-12-30
NO851774L (en) 1985-11-05

Similar Documents

Publication Publication Date Title
ZA856387B (en) Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
AU2748192A (en) 22-methyl-4-aza-21-nor-5alpha-chol-1-en-3,20-dione and 4,22-dimethyl-4-aza-21-nor-5alpha-chol-1-en-3,20-dione as 5alpha-reductase inhibitors
NZ218089A (en) 7-piperazinyl, 4-oxoquinolines and pharmaceutical compositions
GB8521793D0 (en) Analgesic & anti-inflammatory compositions
PH21580A (en) Analgesic and antiinflammatory 1,3 - diacyl - 2 - oxindole compounds
ZA861211B (en) Analgesic composition
ZM785A1 (en) 1,3-disubstituted oxindoles as analgesic and anti-inflammatory agents
NZ217123A (en) 7-alpha-cephalosporins, pharmaceutical compositions and intermediate compounds
ZA861212B (en) Analgesic composition
EP0199235A3 (en) Phenylalkyl-2,3-dihydrobenzofurans and analogs useful as anti-inflammatory agents
ZA853379B (en) Substituted 1-oxa-dethiachphalosporins as anti-inflammatory and antidegenerative agents
PH23498A (en) 3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
ZA851521B (en) Phenylthiomethyl-6-hydroxy-2,3-dihydrobenzo-pyran and analogs thereof useful as anti-inflammatory agents
BR8502769A (en) ORAL, STABLE AND SPARKLING COMPOSITION
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
ZA854947B (en) Beta-lactam derivatives as anti-inflammatory and anti-degenerative agents
ZA851991B (en) 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
NZ217248A (en) Gem-dihalo-1,8-diamino-4-aza-octones and pharmaceutical compositions
IT1200931B (en) TRIAZINIC DERIVATIVES EQUIPPED WITH ANALGESIC, ANTI-PIRETIC AND ANTI-INFLAMMATORY ACTIVITIES
MW1685A1 (en) N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
ZM3185A1 (en) N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
NZ211052A (en) 1,3-disubstituted-2-oxindoles as analgesic and anti-inflammatory agents
EP0172233A4 (en) Punaglandins and pharmaceutical use thereof.
PH23064A (en) Quinolizinone compound and pharmaceutical composition comprising the same
DE3569472D1 (en) Pharmaceutical composition, its production and use